Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
about
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationAlphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.Tetraspanins in viral infections: a fundamental role in viral biology?Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling MiceAlpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infectionAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesRecombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus MacaquesVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsLower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.Alphavirus vectors: development and potential therapeutic applications.Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cellsExpression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsExpression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionModulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.Challenges and opportunities for development of an AIDS vaccine.An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceCytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesHuman immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.Heterologous gene expression from transmissible gastroenteritis virus replicon particles.Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons.Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.Mucosal and systemic adjuvant activity of alphavirus replicon particles.Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesMucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.New hope for an AIDS vaccine.Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signalingInduction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression systemAlphavirus vectors and vaccination.Prospects for an HIV vaccine: conventional approaches and DNA immunization.Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
P2860
Q24634730-D25EB53E-BE75-4515-9365-61958D7934B0Q24796792-9AFA5008-748C-4F4E-8C56-B784359C99A9Q27470936-51583AFA-2695-4BAC-B960-AA7C7F81CDF4Q27472866-107F470C-F724-4FED-B942-190AC2BE4646Q27481478-EA43297F-F9B4-44B6-8C6B-3AB615CBBECAQ27481522-B0A934A6-D2B8-4514-B327-F5E84F43471FQ27489000-9D0314CE-C287-4E89-9705-DD1F50659A0FQ27491052-345AA9DE-8E23-4F83-9BB4-1D76151B520BQ28764574-6D5AAA9D-DBCB-4240-B9EB-91A2D2A433C4Q30373857-1299031F-6D40-445E-8056-0E17CB19DE85Q30771556-9ACDB0A2-992E-4844-B1F0-EFD4FC7321F3Q33351971-404495C7-E966-4D02-922F-89AF05F1E85AQ33737723-36A9B658-DFC8-4C48-A420-D888E16B1C77Q33787304-1B778D6D-DC4E-4982-8121-66881EE943DDQ33835295-4E4E1114-B49F-4884-A394-A7918AF04B73Q33839981-6123DD07-5625-46E2-8690-01F7498DF1CCQ33850032-118836E2-965C-4290-8E30-00820E9C7DB8Q33852720-2F5E77D8-F73B-432B-BC63-29CD7A215713Q33854615-C0F5CD7F-76D7-4B37-A89B-2EED8ACA384CQ33862487-6CFCF478-C632-44FD-A8CE-266DE11CCADCQ33920185-391BECCD-6196-4179-A5E6-2A99B46C39CAQ33942996-1B238E40-CFEE-4979-B231-F114920C357AQ34059308-3E196968-EB59-4C1C-AF06-D001B14244B2Q34228494-7F85E644-D89A-44C0-B79A-4EB02B879CD7Q34255654-B9976969-B5EB-4112-8A17-B1514DFFE734Q34328584-E1C4A735-EFBB-4EDA-B275-92FC0C2C36F1Q34332253-DC085AE7-0C6D-4F96-8A9F-B52DF31BA9DBQ34357038-78F71F07-C664-47A7-B43F-B0D6024864F9Q34410789-B49CD8E3-3D6C-4C1A-A066-E0874732FFEEQ34465510-69727096-E7EE-4483-959A-55520569C5F2Q34471356-7F16C865-44F7-4F11-ACFD-13E811F37F6EQ34491679-9E289D35-1049-40C9-9D81-EC5B8408711FQ34545923-48F733A0-FADC-4DB1-9498-89C01C8D3733Q34632063-683AA9BA-CF35-4D99-9A34-71D2CB21E015Q34651604-F76FFFC7-5C77-4CE7-8C0E-1DDE30830946Q34717846-5D565118-795F-418F-8B44-B5C66026228FQ34754733-C8992609-D1B5-4B1F-BA13-DE3F8436E980Q34812016-5259F894-186F-4EC3-9CEC-AE2FBCE48B0BQ35042496-91D961A3-802B-49A1-840D-82C7C2F65527Q35076961-DB07942C-8189-4F84-9D02-E32DB9DB1FEE
P2860
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Vaccination of macaques agains ...... itis virus replicon particles.
@en
Vaccination of macaques agains ...... itis virus replicon particles.
@nl
type
label
Vaccination of macaques agains ...... itis virus replicon particles.
@en
Vaccination of macaques agains ...... itis virus replicon particles.
@nl
prefLabel
Vaccination of macaques agains ...... itis virus replicon particles.
@en
Vaccination of macaques agains ...... itis virus replicon particles.
@nl
P2093
P2860
P1433
P1476
Vaccination of macaques agains ...... itis virus replicon particles.
@en
P2093
D M Irlbeck
J A Frelinger
K M McGrath
M J Connell
P R Johnson
R E Johnston
P2860
P304
P356
10.1128/JVI.74.1.371-378.2000
P407
P577
2000-01-01T00:00:00Z